These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27741131)

  • 1. Quality of pharmacoeconomic research in China: A systematic review.
    Ma H; Jian W; Xu T; He Y; Rizzo JA; Fang H
    Medicine (Baltimore); 2016 Oct; 95(41):e5114. PubMed ID: 27741131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Review on the Extent and Quality of Pharmacoeconomic Publications for China.
    Jiang S; Ma X; Desai P; Yang L; Rascati K
    Value Health Reg Issues; 2014 May; 3():79-86. PubMed ID: 29702942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of quality of pharmacoeconomic studies involved in traditional Chinese medicine in China.
    Si L; Yin M; Wang J; Yang S; Zhang J; Wei L
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):1049-1060. PubMed ID: 32777958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review and Quality Evaluation of Pharmacoeconomic Studies on Traditional Chinese Medicines.
    Yang N; Zhang H; Deng T; Guo JJ; Hu M
    Front Public Health; 2021; 9():706366. PubMed ID: 34414159
    [No Abstract]   [Full Text] [Related]  

  • 6. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The state of health economic research in South Africa: a systematic review.
    Gavaza P; Rascati KL; Oladapo AO; Khoza S
    Pharmacoeconomics; 2012 Oct; 30(10):925-40. PubMed ID: 22809450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality Assessment of Reporting of Economic Evaluation in Cardiac Sugery: Has it Improved?
    Guerre P; Laaboub N; Colin C; Obadia JF; Julien C; Hrifach A; Rabier H; Serrier H; Grinberg D
    Int J Technol Assess Health Care; 2019 Jan; 35(1):45-49. PubMed ID: 30744730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHARMACOECONOMIC STUDIES IN WORLD HEALTH ORGANIZATION EASTERN MEDITERRANEAN COUNTRIES: REPORTING COMPLETENESS.
    Alefan Q; Rascati K
    Int J Technol Assess Health Care; 2017 Jan; 33(2):215-221. PubMed ID: 28578712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting quality of economic evaluations of the negotiated Traditional Chinese Medicines in national reimbursement drug list of China: A systematic review.
    Yan J; Bao S; Liu L; Zhang YQ; Ming J; Wei Y; Chen Y
    Integr Med Res; 2023 Mar; 12(1):100915. PubMed ID: 36632129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Quality of Pharmacoeconomic Studies in Asia-Pacific Region and Identification of Influencing Variables.
    Pandey P; Pandey RD; Shah V
    Value Health Reg Issues; 2018 May; 15():70-75. PubMed ID: 29474182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality assessment of pharmacoeconomic abstracts of original research articles in selected journals.
    Trakas K; Addis A; Kruk D; Buczek Y; Iskedjian M; Einarson TR
    Ann Pharmacother; 1997 Apr; 31(4):423-8. PubMed ID: 9101002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Extent and Quality of Pharmacoeconomic Studies in India Using Quality of Health Economic Studies Score: A Targeted Literature Review.
    Patel N; Yanamala S; Rai M
    Value Health Reg Issues; 2024 May; 41():41-47. PubMed ID: 38237328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sponsorship bias in published pharmacoeconomic evaluations of national reimbursement negotiation drugs in China: a systematic review.
    He Z; Huang X; Chen D; Wang G; Zhu Y; Li H; Han S; Shi L; Guan X
    BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 38030227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review on the Extent and Quality of Pharmacoeconomic Publications in Egypt.
    Farid S; Elmahdawy M; Baines D
    Clin Drug Investig; 2019 Feb; 39(2):157-168. PubMed ID: 30460486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review of Methods and Study Quality of Economic Evaluations for the Treatment of Schizophrenia.
    Wang L; Shi F; Guan X; Xu H; Liu J; Li H
    Front Public Health; 2021; 9():689123. PubMed ID: 34746073
    [No Abstract]   [Full Text] [Related]  

  • 18. A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis.
    Hiligsmann M; Evers SM; Ben Sedrine W; Kanis JA; Ramaekers B; Reginster JY; Silverman S; Wyers CE; Boonen A
    Pharmacoeconomics; 2015 Mar; 33(3):205-24. PubMed ID: 25377850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the quality of pharmacoeconomic evaluation literature in China.
    Zhang F; He X; Xiang W; Li SC
    J Med Econ; 2017 May; 20(5):510-517. PubMed ID: 28125918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of Elbasvir/Grazoprevir for the Treatment of Chronic Hepatitis C: A Systematic Review.
    Liu J; Guo M; Ke L; You R
    Front Public Health; 2022; 10():836986. PubMed ID: 35646774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.